Revolutionizing Cardiac Care: INVAMED Introduces Respiratory-Controlled Cardiac Pacemaker and ICD Technologies with Artificial Intelligence
INVAMED Revolutionizes Cardiac Care with AI-Powered Pacemaker and ICD Technologies
ISTANBUL – Turkish medical firm INVAMED has made a groundbreaking advancement in cardiac care by introducing respiratory-controlled cardiac pacemaker and Implantable Cardioverter Defibrillator (ICD) technologies integrated with artificial intelligence.
Developed in collaboration with experts in cardiology and cardiac surgery from around the world, INVAMED’s innovative technologies are set to transform the way heart health is managed. The respiratory-controlled cardiac pacemaker, supported by AI algorithms, can adapt to changes in a patient’s respiratory rate and depth in real-time, optimizing the heart’s electrical activity for improved energy efficiency and cardiac performance.
The ICD technology, on the other hand, not only detects potential life-threatening ventricular arrhythmias but also features an upgradeable intelligence feature that assists doctors in creating personalized treatment protocols. By utilizing a simulator developed by INVAMED, the performance of these technologies can be tested in a clinical setting, ensuring maximum safety and effectiveness in treatment processes.
With cardiovascular diseases claiming the lives of 17 million people annually according to the World Health Organization, INVAMED’s mission is to revolutionize heart health and reduce the global burden of heart-related illnesses. President Rasit Dinc expressed his excitement for the future of cardiovascular treatment, stating that INVAMED will continue to lead the way in medical innovation through scientific research.
The introduction of these cutting-edge technologies marks the beginning of a new era in cardiac care, offering hope for millions of patients worldwide.INVAMED’s commitment to advancing medical technology is set to make a significant impact on the field of cardiology and improve the lives of countless individuals suffering from heart conditions.
